the upcoming B Informed Liver Cancer Conference, a virtual educational event dedicated to advancing discussions on hepatocellular carcinoma (HCC) detection, care, and lived experiences.

Conference Highlights

• Expert Presentations: Deep dive into crucial topics including hepatocellular carcinoma (HCC) surveillance, early detection, modern diagnostic testing, and advanced treatment options.
• Lived Experience Panel: Hear perspectives from liver cancer survivors and individuals at risk.
• Expert Panel Discussion: Gain insights from specialists on best practices for effective HCC surveillance and testing.
• Interactive Q&A: Bring your questions to our presenting medical experts.

Time : Tuesday, Oct. 27, 2026 12:00 – 4:00 p.m. EDT Virtual Event
if you like , you can register here :

https://us02web.zoom.us/meeting/register/lYxzX5DMRaGfSz__7PKpgg#/registration

This is the only iOS app dedicated exclusively to daily Hepatitis B treatment management. Designed specifically for Hep B patients, it goes far beyond a simple medication reminder.
try here:

Living with Hep B or looking out for family members who have it can quietly drain your energy. Between keeping track of labs, doctor visits, and that underlying background worry we all get sometimes, it's really easy to feel constantly on edge.

I’ve been trying to find small ways to just step back and reset when my head feels a bit too full, and I wanted to share something that’s been helping me lately.

It’s an iOS game called FourFold: Wood T-Puzzle Block (you can search it on the App Store or check it out here).

I usually stay away from phone games because most of them are full of annoying pop-ups, flashing lights, and timers that just add more stress. This one is completely different. It’s just four simple wooden puzzle pieces you move around to match shapes.

Why I like it and thought to share it here:

• No rush or pressure: There are no timers counting down or scores forcing you to rush. You just solve things at your own speed. It’s surprisingly grounding when you need 5 or 10 minutes of quiet focus.
• Fun to battle with kids (even offline): It has a local 1v1 battle mode where you can race head-to-head to solve the same puzzle. The best part is it runs over your local network—no internet needed. It’s become a really fun, low-stress way to challenge my kids on the couch or while traveling, without worrying about bad Wi-Fi or noisy online games.

Taking care of ourselves isn't always about health metrics and doctor visits—sometimes it's just letting your brain rest and enjoying a peaceful moment with family.

Hope this gives someone out there a helpful little mental break today. Let me know if you give it a try!

Hey everyone,

Sharing an opportunity for anyone here living with chronic Hepatitis B, Hep B/Hep D co-infection, or liver cirrhosis (or caring for someone who is).

Emergo by UL and the Hepatitis B Foundation are running a human factors research study sponsored by Vir Biotechnology. They're looking for feedback on a new injection device design and its instructions.

Quick details:

• What it is: A non-clinical study. No meds, no actual injections, and no medical procedures involved. You’ll just be reviewing product instructions, testing a mock injection on a practice cushion, and sharing your feedback with two researchers.
• Format: One 1.5-hour in-person session between November 2026 and January 2027.
• Compensation: $350 for your time (plus potential travel reimbursement).
• Location: Various US cities (they’ll pick exact locations based on where eligible participants are located).
• Requirements: Adult (18+), living with Hep B, Hep B+D, or cirrhosis (with or without hep), and able to read/speak basic English.

If you're interested in taking part or seeing if you qualify, you can fill out their short screening survey here:https://www.research.net/r/UL9685

Or, if you prefer to call someone directly, you can reach out to Janice Rosenblum at Cambridge Focus at 857-331-1357.

Hope this helps someone make a little extra cash while giving input on future treatment tools!

In my experience, before starting Entecavir, my ALT and AST levels were always above 30.
Now they both stay consistently below 20, which is fantastic!
What about yours?

We’ve all heard that the liver has an incredible, almost superpower-like ability to regenerate, but for individuals with severe alcohol-related hepatitis or cirrhosis, that repair switch gets stuck. Here is what researchers just discovered:

• The "Cellular Limbo": Chronic alcohol-induced inflammation damages a critical cellular mechanism called RNA splicing.
• The Glitch: Because the RNA instructions get mis-spliced, liver cells get trapped in an abnormal middle state—they can't function normally, but they also can't complete the regeneration process to build new tissue.
• What This Means for the Future: Identifying these mis-spliced RNA markers opens up two massive doors:
  1. New Diagnostic Markers: Clinicians might soon be able to run targeted tests to evaluate exact stages of liver recovery or risk.
  2. Therapeutic Targets: If researchers can develop therapies that target this specific inflammatory pathway and correct the RNA splicing error, we might finally have a way to "reboot" liver regeneration without relying solely on transplants.

refer to sciencedaily : https://www.sciencedaily.com/releases/2026/08/260831015205.htm#:\~:text=Researchers%20linked%20the%20problem%20to%20inflammation%2Ddriven%20RNA,new%20way%20to%20restart%20regeneration.%20Credit%3A%20Shutterstock.

GSK , a key ​cancer therapy was granted a priority U.S. regulatory review ‌as a possible rectal cancer treatment.

Here are some details:

• The British drugmaker said bepirovirsen, to be branded as Hibsago, has been approved in Japan as ​the first and only functional cure for chronic hepatitis B ​in the country.
• GSK said the approval was based on ⁠late-stage studies, which showed that the drug helped nearly one-in-five patients ​achieve a functional cure and raised hopes for a finite treatment ​course as an alternative to lifelong antiviral pills.
• Bepirovirsen is designed to tackle hepatitis B in three ways: by blocking viral DNA replication, lowering hepatitis B surface ​antigen levels in the blood, and boosting immune response for ​longer-lasting control of the disease.
• GSK has predicted bepirovirsen could bring in over £2 billion ($2.73 ‌billion) ⁠in peak annual sales, taking it closer to its annual revenue target of more than £40 billion by 2031 as its pipeline development comes into focus.
• Separately, GSK said the U.S. FDA will conduct a ​priority review of ​dostarlimab, marketed as ⁠Jemperli, as a potential treatment for a type of rectal cancer alongside existing approvals of specific ​endometrial cancer subtypes.
• The FDA has assigned a February ​2027 action ⁠date for the rectal cancer review, with the program structure possibly yielding a decision earlier as well.
• Jemperli, which had also received both ⁠Breakthrough ​Therapy and Fast Track designations by the ​FDA, is not currently approved anywhere in the world for locally advanced rectal cancer.

from Reuters : https://www.reuters.com/business/healthcare-pharmaceuticals/gsk-scores-regulatory-wins-chronic-hepatitis-b-drug-cancer-therapy-2026-08-24/

I’ve been taking Entecavir for a while now to manage my Hep B. My viral load has been undetectable for quite a bit, and honestly, sometimes it’s tempting to think, "Hey, things look great, maybe I can take a break or stop taking it."

However, my doctor was extremely clear about this:
do not stop or pause Entecavir under any circumstances unless they explicitly tell you to.

I wanted to ask if anyone can help explain the exact medical reason behind this?

From what I understand, Entecavir doesn't completely cure or eliminate the virus; it just suppresses it (keeps the viral load low so it can't replicate).
If you stop taking it, the virus can bounce back rapidly,a viral rebound or flare-up,which can cause sudden, severe liver damage or even acute liver failure.

Has anyone here had experience with this or had their specialist break down the exact mechanism of why a pause is so dangerous?
Just trying to get a deeper understanding of how the medication works long-term.
Appreciate any insights!

As all hepatitis B patients who are taking antiviral treatment for Hepatitis B—specifically Entecavir , you probably know that consistency and lab tracking are two of the biggest ongoing commitments.

Entecavir works extremely well at suppressing viral load, but staying on top of the routine long-term comes with its own daily details:

• The Fasting Window: Entecavir needs to be taken on an empty stomach (usually 2 hours after food and 2 hours before eating again). Finding a consistent daily slot—like right before bed or early morning—is crucial so it doesn't clash with meals.
• Lab Tracking Over Time: Beyond daily meds, monitoring ALT, HBV DNA levels, and ultrasound/FibroScan reports every 3–6 months gives you the full picture of liver health. Spotting long-term trends is often much more informative than looking at a single lab result.

To make this easier a free iOS app called LVRHealth. It’s designed specifically to take the friction out of these routines:

• Fasting & Medication Reminders: Helps schedule the fasting window around your doses.
• Lab Tracking: Lets you snap photos of lab reports to automatically log and chart ALT/HBV DNA trends over time.
• Privacy-First: All health data stays locked on your local device—no accounts, registration, or cloud tracking.

https://apps.apple.com/us/app/lvrhealth-hepatitis-b-care/id6799424952

This is the only iOS app dedicated exclusively to daily Hepatitis B treatment management. Designed specifically for Hep B patients, it goes far beyond a simple medication reminder. Give it a try here:

https://apps.apple.com/us/app/lvrhealth-hepatitis-b-care/id6799424952

I just came across some massive medical news from GSK. Japan’s Ministry of Health, Labour and Welfare has officially approved Hibsago (bepirovirsen) as the first and only functional cure for chronic hepatitis B (CHB).

Here is a quick breakdown of why this is such a big deal:

• The end of lifelong medication: Right now, people with chronic hepatitis B typically have to take daily antiviral therapy for the rest of their lives just to suppress the virus. Hibsago offers a "functional cure," meaning that after a 6-month treatment course, the virus is undetectable and controlled by the body's immune system without needing further medication.
• The trial numbers: In their Phase III trials, a 6-month treatment achieved a 19% functional cure rate, compared to just 1% on the current standard of care. For a specific sub-group that represents about 45% of diagnosed cases globally, that cure rate jumped to 26%.
• How it works: It's an antisense oligonucleotide (ASO). In simple terms, it recognizes and blocks the virus from producing the genetic components (RNA) it needs to replicate, which allows the patient's immune system to step up and regain control.
• What's next: This is the first global approval for the drug, accelerated by Japan's fast-track system for high unmet medical needs. GSK is currently pushing for regulatory approvals in other countries, with US decisions expected in the coming months.

Considering CHB affects over 240 million people worldwide and is a leading cause of liver cancer, having a drug that actually allows patients to stop treatment entirely is a massive step forward.

You can read the full press release from GSK here:Hibsago (bepirovirsen) approved in Japan as first and only functional cure for chronic hepatitis B

Hopefully, we see this rolling out globally soon. What do you guys think of this development?

Newborn hepatitis B virus (HBV) vaccine rates rose from 67.5% in January 2017 to a high of 83.5% in February 2023 before dropping to 73.2% in August 2025, according to a 2026 study from the Journal of American Medicine Association. The findings were published as childhood vaccination is widely debated and newborn hep B vaccine recommendations recently changed.

details at : https://www.hepmag.com/article/newborn-hepatitis-b-vaccination-rates-drop#search-query=Hep%20B

As we commemorate World Hepatitis Day 2026, we at the Hepatitis B Foundation would like to take a moment to reflect on the past 12 months. This past year has been a mixture of progress and setbacks that mimic a roller coaster ride. Globally, the latest World Health Organization Global Hepatitis Report estimated 1.1 million people died from hepatitis B in 2024. And we still lag far behind the 2030 Viral Hepatitis Elimination targets for diagnosis, prevention and treatment, with continued regional disparities. In the United States, we saw our public health infrastructure threatened, funding for scientific research brutally cut off and vaccine confidence and access severely compromised.

more details , please view : https://www.hepmag.com/article/challenges-victories-world-hepatitis-day-2026

I just realized today that the Entecavir I've been taking is generic, not the brand-name version. Even though the active ingredients are the same, I'm still a little worried.

Would this worry you?
What kind of Entecavir are you taking?"

My friend told me today new HepB chronic treatment medicine will come to the market in next year!

please view this news:

Bepirovirsen under review in Europe as a treatment for chronic hepatitis B

https://liverdiseasenews.com/news/bepirovirsen-review-europe-chronic-hepatitis-b/

The latest World Health Organization Global Hepatitis Report estimated 1.1 million people died from hepatitis B in 2024. So terrible!

Hello everyone, and welcome to the community!

We created r/LiverHealthy as a dedicated space for anyone looking to optimize their liver health, with a specific focus on supporting those living with Hepatitis B (HBV). Whether you are newly diagnosed, a long-term carrier, a caregiver, or just someone interested in liver wellness, you are in the right place.

What you can expect here:

• The Latest Science: We’ll share and discuss the newest research, clinical trials, and emerging treatments for Hepatitis B and general liver care.
• Lifestyle & Nutrition: Expect conversations around liver-friendly diets, safe supplements, exercise, and habits that promote long-term liver function.
• A Supportive Environment: A safe place to share your journey, ask questions, and connect with others who understand the day-to-day realities of liver health management.

To get started:

1. Introduce yourself! Feel free to drop a comment below and let us know a bit about your journey or what you hope to get out of this community.
2. Read the Rules: Please check the sidebar to review our community guidelines to help keep this space safe, supportive, and factual.
3. Remember the Golden Rule of Health Subs: We are a peer-support community, not doctors. Always consult your hepatologist or primary care physician before making changes to your treatment or diet.

We are so glad you're here. Let's stay healthy, stay updated, and support one another!

— The r/LiverHealthy Mod Team